Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival Eli Lilly discounted some of its Zepbound injections last week. The Danish … [+398 chars]
Novo Nordisk to cut price of Wegovy amid rising weight-loss drug competition - Semafor
Pharma giants face growing competition from copycat weight-loss drugs, as patents near expiration.
By:Madeleine Wright, Jeronimo Gonzalez
Source:Semafor.com
Published:
Related News
Stock Market News for Jan. 23, 2026: Dow Drops; Intel Stock Slides - The Wall Street Journal
Dollar tumbles against the yen, while gold prices hit record
The Wall Street Journal•Heard Editors, Paulo Trevisani, WSJ Staff, Hannah Erin Lang, Dean Seal, Dan Gallagher, Ryan Dezember, David Benoit, Xavier Martinez, Jacob Passy, Matt Grossman
Dow Jones Futures: Tesla, Microsoft, Meta, Apple Lead Earnings Wave; What To Do Now - Investor's Business Daily
The major indexes are all above key levels, while small caps are at record highs.
Investor's Business Daily
Analyst sends blunt 3-word warning on Intel stock after earnings - thestreet.com
Here’s what could be next for Intel stock.
TheStreet•Silin Chen